278 related articles for article (PubMed ID: 19715848)
1. De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
Crespo M; Mir M; Marin M; Hurtado S; Estadella C; Gurí X; Rap O; Moral R; Puig JM; Lloveras J
Transplant Proc; 2009; 41(6):2115-7. PubMed ID: 19715848
[TBL] [Abstract][Full Text] [Related]
2. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
3. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
4. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.
Hougardy JM; Broeders N; Kianda M; Massart A; Madhoun P; Le Moine A; Hoang AD; Mikhalski D; Wissing KM; Abramowicz D
Transplantation; 2011 Mar; 91(5):566-9. PubMed ID: 21192316
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
6. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
[TBL] [Abstract][Full Text] [Related]
7. Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients.
Wu MJ; Cheng CY; Chen CH; Wu WP; Cheng CH; Yu DM; Chuang YW; Shu KH
Transplantation; 2011 Sep; 92(6):648-52. PubMed ID: 21912349
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring in de novo kidney transplant receiving the modified-release once-daily tacrolimus.
Jelassi ML; Lefeuvre S; Karras A; Moulonguet L; Billaud EM
Transplant Proc; 2011 Mar; 43(2):491-4. PubMed ID: 21440742
[TBL] [Abstract][Full Text] [Related]
9. A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients.
van Hooff JP; Squifflet JP; Wlodarczyk Z; Vanrenterghem Y; Paczek L
Transplantation; 2003 Jun; 75(12):1934-9. PubMed ID: 12829890
[TBL] [Abstract][Full Text] [Related]
10. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351
[TBL] [Abstract][Full Text] [Related]
11. Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients.
Chan L; Hartmann E; Cibrik D; Cooper M; Shaw LM
Transplantation; 2010 Jul; 90(1):31-7. PubMed ID: 20517177
[TBL] [Abstract][Full Text] [Related]
12. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial.
Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M
Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831
[TBL] [Abstract][Full Text] [Related]
13. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus prolonged release in kidney transplantation.
Krämer BK
Expert Rev Clin Immunol; 2009 Mar; 5(2):127-33. PubMed ID: 20477061
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
17. Three-month experience with tacrolimus once-daily regimen in stable renal allografts.
Diez Ojea B; Alonso Alvarez M; Aguado Fernández S; Baños Gallardo M; García Melendreras S; Gómez Huertas E
Transplant Proc; 2009; 41(6):2323-5. PubMed ID: 19715908
[TBL] [Abstract][Full Text] [Related]
18. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
[TBL] [Abstract][Full Text] [Related]
19. Conversion to tacrolimus extended-release formulation: short-term clinical results.
Gallego-Valcarce E; Ortega-Cerrato A; Llamas-Fuentes F; Martinez-Fernandez G; Perez-Martinez J; Gomez-Roldan C
Transplant Proc; 2009; 41(6):2326-7. PubMed ID: 19715909
[TBL] [Abstract][Full Text] [Related]
20. De novo Prograf versus de novo Advagraf: are trough level profile curves similar?
Sarvary E; Wagner L; Telkes G; Gaman G; Varga M; Gaal I; Mathe Z; Chmel R; Fehervari I; Langer RM
Transplant Proc; 2014; 46(6):2164-7. PubMed ID: 25131131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
